Sialic acids are a ubiquitous family of negatively charged sugar molecules found on the surfaces of mammalian cells, usually at the termini of glycans attached to glycoproteins, glycosphingolipids, and the proteoglycan keratan sulfate (2, 10, 72). Sialic acid is an essential component of cell surface receptors for a variety of microorganisms and microbial toxins (2, 34, 47) . Members of at least eight different virus families-Ortho-
Sialic acids are a ubiquitous family of negatively charged sugar molecules found on the surfaces of mammalian cells, usually at the termini of glycans attached to glycoproteins, glycosphingolipids, and the proteoglycan keratan sulfate (2, 10, 72) . Sialic acid is an essential component of cell surface receptors for a variety of microorganisms and microbial toxins (2, 34, 47) . Members of at least eight different virus families-Orthomyxoviridae (63) , Paramyxoviridae (62) , Coronaviridae (40) , Reoviridae (3, 6, 20) , Picornaviridae (1, 32, 55, 61, 70, 71, 80) , Parvoviridae (33, 73, 75) , Papovaviridae (8, 12, 25, 43) , and Adenoviridae (4, 5)-including enveloped and nonenveloped viruses and RNA and DNA viruses, exploit sialoglycoconjugates for attachment. Sialic acid is normally linked to underlying glycans by ␣2,3 or ␣2,6 bonds to a galactose moiety or by ␣2,8 bonds to an internal sialic acid (2, 72) . Combinations of different glycosidic linkages and numerous substitutions that can occur on the pyranoside ring and side chains of sialic acid generate considerable diversity in sialic acid structure. Some viruses bind preferentially to sialic acid attached by a particular glycosidic linkage (4, 29, 33, 43, 49, 51) , and this specificity may contribute to virus host range, tissue tropism, and pathogenesis. For example, the preference of human and avian influenza A hemagglutinins (HAs) for ␣2,6-or ␣2,3-linked sialic acid, respectively, correlates with the abundance of these linkages on their target cells, respiratory epithelial cells in humans and intestinal cells in birds (16, 44, 45, 49) .
Enterovirus 70 (EV70), the causative agent of acute hemorrhagic conjunctivitis, exhibits a restricted in vivo tropism for the human conjunctival and corneal epithelium and has also been associated, in rare instances, with neurological sequelae (69, 77, 78) . In vitro, EV70 replicates in cells derived from a wide variety of mammalian species (79) . Because virus receptors are recognized as important determinants of host range, tissue tropism, and pathogenesis (23, 54) , the identification of EV70 receptors should help to explain the unique properties of this virus. Previously, we demonstrated that the glycosyl phosphatidylinositol (GPI)-linked protein CD55 plays a major role in EV70 binding to, and infection of, HeLa cells (35, 36) . However, EV70 attachment to all other human cell lines that we have tested was CD55 independent but required sialic acid, as determined by sensitivity to Vibrio cholerae sialidase, and sialidase treatment of HeLa cells also reduced EV70 binding (1, 28) . Like EV70, both adenovirus 37 and some avian influenza A viruses, in particular H7 subtypes, are associated with eye infections (4, 5, 13, 24, 39, 64) . Adenovirus 37 (4, 5) and avian influenza viruses (14, 31, 51, 52) recognize receptors containing ␣2,3-linked sialic acid, suggesting that this specificity contributes to the ocular tropism of these viruses. We hypothesized that EV70 would also recognize ␣2,3-linked sialic acid. Using a combination of linkage-specific sialidases, sialyltransferases, and lectins, we demonstrate that EV70 exhibits a strong preference for binding to ␣2,3-linked sialic acid on the surfaces of U-937 cells and human corneal epithelial cells. We also provide evidence that attachment molecules for EV70 on corneal epithelial cells are proteinaceous while the molecules recognized by EV70 on the surfaces of U-937 cells are not.
MATERIALS AND METHODS
Viruses and cell lines. The EV70 prototype strain J670/71 was obtained from M. Hatch and M. Pallansch (Centers for Disease Control and Prevention, Atlanta, GA). EV70 was propagated and infectious titers were determined in LLC-MK 2 rhesus macaque kidney cells as described previously (35) . U-937 cells, HeLa T4 cells, and LLC-MK 2 cells were maintained in culture as described previously (1, 28) . Human corneal epithelial (HCE) cells immortalized with SV40 large T antigen (26) were propagated in keratinocyte serum-free medium (Invitrogen Life Technologies, Burlington, ON, Canada) supplemented with bovine pituitary extract (25 g/ml; Invitrogen) and recombinant epidermal growth factor (0.2 ng/ml; Invitrogen).
Time course of EV70 replication in U-937 cells. U-937 cells were counted, washed once, resuspended to a cell density of 3.0 ϫ 10 7 /ml, and infected at a multiplicity of infection (MOI) of 5 PFU/cell in a final volume of 100 l of OptiMEM (Invitrogen) for 1 h at 32°C. Infected cells were washed three times with 3 ml of medium to remove unbound virus and resuspended in a final volume of 8 ml RPMI 1640 (Sigma). Duplicate 1-ml aliquots were withdrawn immediately and at various times after infection and frozen at Ϫ80°C. Following two or three cycles of freezing and thawing, the amount of infectious virus in each sample was determined by plaque assay on monolayers of LLC-MK 2 cells (35) .
Virus binding assays. 35 S-labeled EV70 was harvested from LLC-MK 2 cells and purified by sucrose gradient ultracentrifugation as described previously (35) . Preparations of radiolabeled EV70 contained approximately 10 8 PFU/ml. The total amount of protein in virus preparations was determined and purity was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Using these values, we estimated particle/PFU ratios to be Ն2,000:1. For virus binding assays, suspension cells were washed once and resuspended to a cell density of 2.5 ϫ 10 6 /ml in OptiMEM containing 0.1% (wt/vol) sodium azide, and nonsaturating amounts (1 to 4 l) of radiolabeled EV70 were added per 200-l sample. Following a 1-h incubation at 32°C, radioactivity in bound and unbound fractions was determined by liquid scintillation counting (35) . In these studies, U-937 cells bound 20 to 30% of input radiolabeled EV70. HCE cells were dispersed with 0.05% trypsin-EDTA, washed three times in OptiMEM, and counted before use in binding assays. Typically, HCE cells bound 12 to 18% of input radiolabeled EV70, and there was little or no difference in the extents of EV70 binding to HCE cells dispersed with trypsin-EDTA or with EDTA alone (data not shown). To confirm the specificity of virus attachment, radiolabeled virus was incubated for 1 h with ev-12, an EV70-specific neutralizing monoclonal antibody (76) .
Sialidase treatment of cells. Streptococcus pneumoniae (Glyko 80020) and Clostridium perfringens (Glyko 80030) sialidases were purchased from Prozyme (San Leandro, CA). Vibrio cholerae sialidase was obtained from Roche (Laval, QC, Canada; no. 1080725). U-937 cells were pelleted, washed, and resuspended to a cell density of 5 ϫ 10 7 /ml in OptiMEM containing 0.1% (wt/vol) sodium azide. The cells were incubated at 37°C for 30 min in the presence or absence of sialidase (10 to 100 mU/ml). Adherent cells were dispersed with trypsin-EDTA, washed three times, and incubated using identical conditions. For V. cholerae sialidase, OptiMEM (adjusted to pH 5.7) was supplemented with 4 mM CaCl 2 . After sialidase treatment, the cells were washed twice, counted, and used in virus binding assays or for infection. Using similar reaction conditions and 2Ј-(4-methylumbelliferyl)-␣-D-N-acetylneuraminic acid (Sigma) as a substrate (56) , the relative activities of the three sialidases were as follows: C. perfringens sialidase Ͼ V. cholerae sialidase Ͼ S. pneumoniae sialidase (data not shown). The addition of protease inhibitors during incubation of cells with sialidase did not alter the results (data not shown), indicating that the effects seen were not due to protease contamination of the sialidases.
Sialyltransferase treatment of U-937 cells. ␣2,3(N) (ST3GalIII), ␣2,3(O) (ST3GalII) and ␣2,6(N) (ST6GalI) sialyltransferases (Calbiochem/Merck products) were purchased from VWR Canlab (Mississauga, ON, Canada). U-937 cells were pelleted, washed twice, and resuspended in OptiMEM (pH 5.7; 4 mM CaCl 2 ) to a final cell density of 5 ϫ 10 7 /ml. The cells were then incubated in the presence or absence (untreated control) of 50 mU/ml V. cholerae sialidase for 30 min at 37°C, washed twice, and reuspended in OptiMEM (pH 7.2) to a final cell density of 4.5 ϫ 10 7 /ml. Sialyltransferase (50 mU/ml) and CMP-␤-D-sialic acid (1 mM; VWR Canlab) were added to one aliquot of sialidase-treated cells. All three samples (untreated control cells, sialidase-treated cells, and sialidase-and sialyltransferase-treated cells) were incubated for 4 h at 37°C. The cells were washed twice in OptiMEM and counted, and cell viability was assessed by staining with trypan blue. The cells were pelleted, resuspended to a cell density of 10 7 /ml, and used in binding assays.
Lectin blockade of EV70 binding. Lectins SNA (Sambucus nigra), MAL I (Maackia amurensis leukoagglutinin), and MAL II (Maackia amurensis hemagglutinin) were purchased from Vector Laboratories (Burlington, ON, Canada). U-937 cells were pelleted, washed, resuspended to a cell density of 3.5 ϫ 10 6 /ml in OptiMEM in the presence or absence of lectin, and incubated for 30 min at room temperature. The cells were then washed once, and virus binding was assessed. HCE cells were dispersed with trypsin-EDTA and washed three times before incubation with lectin.
Antibody blockade of EV70 binding. The monoclonal antibody EVR1, which is specific for complement control protein repeat 1 of human CD55 (35) , was provided by E. Altman (National Research Council of Canada, Ottawa, ON, Canada). Cells (10 6 /ml) were washed once and incubated in the presence or absence of 17.5 g/ml of monoclonal antibody EVR1 for 1 h at 37°C. This concentration of EVR1 saturates binding sites on several cell lines (data not shown). The cells were then washed and used in virus binding assays. HCE cells were dispersed with trypsin-EDTA and washed three times before incubation with EVR1.
Flow cytometry. To monitor cell surface CD55, cells were washed once in flow cytometry buffer (PBS containing 2% [wt/vol] bovine serum albumin and 0.1% [wt/vol] sodium azide) and then resuspended (3 ϫ 10 5 cells/sample) in 150 l of flow cytometry buffer containing monoclonal antibody EVR1 for 15 min at room temperature. Adherent cells were dispersed with trypsin-EDTA and washed three times before incubation with EVR1. The cells were washed with 4 ml of PBS-azide and resuspended in 150 l of flow cytometry buffer containing a 1:1,000 dilution of fluorescein isothiocyanate (FITC)-conjugated goat antimouse immunoglobulin (Roche) for 15 min at room temperature. The cells were diluted in flow cytometry buffer and analyzed using a Coulter EpicsXL-MCL flow cytometer. A minimum of 5,000 events were counted for each sample in the established gate, and mean fluorescence intensities were determined from singleparameter histograms generated with Epics XL 1.5 software. Controls for autofluorescence and nonspecific secondary antibody binding were included in each analysis. The binding of FITC-conjugated SNA, MAL I, and biotinylated MAL II was used to monitor saturation of lectin binding. The relative levels of MAL I and SNA binding sites on cells were also compared using FITC-tagged lectins (FITC-tagged MAL II was not available). The cells were washed and resuspended (3 ϫ 10 5 cells/sample) in 150 l of OptiMEM containing 0.1% (wt/vol) sodium azide and 50 g/ml of lectin conjugate for 30 min at room temperature. The cells were then washed and resuspended in OptiMEM-azide and analyzed as described above. The cells incubated with biotinylated MAL II were washed and incubated in OptiMEM containing sodium azide and a 1:500 dilution of phycoerythrin-conjugated streptavidin (1-g/ml stock; Vector Laboratories). Controls for autofluorescence and/or phycoerythrin-streptavidin were included in each analysis.
PiPL-C treatment of cells. Cells were washed three times with PBS, resuspended to a final density of 5 ϫ 10 7 /ml in 50 l phosphatidylinositol-specific phospholipase C (PiPL-C) buffer (RPMI 1640, 0.2% bovine serum albumin, 50 M 2-mercaptoethanol, 10 mM HEPES, 0.1% sodium azide) in the presence or absence of Bacillus cereus PiPL-C (6 U/ml; Sigma), and incubated at 37°C for 90 min. The cells were washed, and virus binding was assessed. A portion of each sample of cells was analyzed by flow cytometry to monitor the extent of enzymatic removal of CD55 from the surfaces of cells. Under these conditions, Ͼ70% of CD55 was removed from the surfaces of U-937 (28) and HCE (data not shown) cells.
Inhibition of N-and O-linked glycosylation.
To inhibit N-linked glycosylation, cells were incubated in culture medium containing 0.2 mg/ml tunicamycin (Sigma) for 24 h. To inhibit O-linked glycosylation, cells were incubated in culture medium containing 3 mM benzyl N-acetyl-␣-D-galactosaminide (benzylGalNAc; Sigma) for 48 h. These conditions have been shown by us (1) and by others (21, 27, 41, 48) to inhibit glycosylation of proteins. The cells were washed twice with PBS, and virus binding was assessed.
Proteinase K treatment of cells. HCE cells were dispersed with trypsin-EDTA. HCE and U-937 cells were washed twice, counted, resuspended in OptiMEM to a cell density of 4.5 ϫ 10 7 /ml, and then incubated in the presence or absence of proteinase K (200 g/ml; Roche) for 2 h at 37°C. An equal volume of PBS containing 6% fetal bovine serum, 2 mM phenylmethylsulfonyl fluoride, and 2ϫ concentrated protease inhibitor cocktail (Sigma) was added to inactivate proteinase K. After a 10-min incubation at room temperature, the cells were washed twice and resuspended to a cell density of 3.5 ϫ 10 7 /ml before being used in virus binding or infectious-center or replication assays. For infectious-center assays, virus binding was done at 4°C to reduce virus entry. The cells were then treated a second time with proteinase K at 32°C for 30 min to eliminate surface-bound virus, washed three times, and resuspended in OptiMEM. The cells were counted and diluted, and the number of infected cells was determined by plaque assay on 7088 NOKHBEH ET AL. J. VIROL.
monolayers of LLC-MK 2 cells. For replication assays with HCE cells, individual wells in six-well culture dishes were seeded with 3.5 ϫ 10 5 cells in a volume of 1 ml. Infected HCE cells settled and adhered within 2 h. At various times after infection, the plates were placed at Ϫ80°C. Following two or three cycles of freezing and thawing, the amount of infectious virus in each sample was determined by plaque assay on monolayers of LLC-MK 2 cells.
RESULTS

EV70
binding is sensitive to sialidase, having specificity for ␣2,3-linked sialic acid. In previous work, we demonstrated that EV70 binding to and infection of several different cell lines were sensitive to prior incubation with V. cholerae sialidase (1, 28) . As a first step in determining if EV70 attachment shows specificity for the sialic acid linkage, we tested two other sialidases that exhibit more specificity for the bond linking sialic acid to underlying sugars for their abilities to inhibit attachment of radiolabeled EV70 to U-937 cells. U-937 cells were chosen for these experiments because they are permissive for EV70 and bind substantial amounts of virus. EV70 binding to U-937 cells is also very sensitive to V. cholerae sialidase and independent of CD55. As shown in Fig. 1, pretreatment (76) inhibited virus binding in a dose-dependent manner, confirming the specificity of virus attachment (Fig. 1, inset) .
␣2,3 sialyltransferase partially restores EV70 binding sites on sialidase-treated cells. As another approach to determine if EV70 binds preferentially to ␣2,3-or ␣2,6-linked sialic acid, we stripped EV70 binding sites from the surfaces of U-937 cells with V. cholerae sialidase and then incubated the cells with commercially available sialyltransferases and CMP-␤-D-sialic acid, reasoning that resialylation of the U-937 cell surface by one or more of the sialyltransferases would restore EV70 binding. The nomenclature and specificities of the sialyltransferases used in this study are presented in Table 1 . As shown in Fig These results support the hypothesis that EV70 binds preferentially to ␣2,3-linked sialic acid compared to ␣2,6-linked sialic acid. To confirm that ␣2,6(N) sialyltransferase was functional, we followed the binding of SNA lectin to sialidase-treated cells and to sialidase-and ␣2,6(N) sialyltransferase-treated cells by flow cytometry. SNA preferentially binds ␣2,6-linked sialic acid. Incubation of U-937 cells with V. cholerae sialidase reduced SNA binding by 70 to 75%; subsequent incubation of cells with ␣2,6(N) sialyltransferase partially restored SNA binding to ϳ64% of that of untreated control cells (Fig. 2B) . We also examined the binding of MAL I lectin, which preferentially binds to ␣2,3-linked sialic acid; however, we saw no decrease in MAL I binding to U-937 cells following sialidase treatment (data not shown). This may be explained by the fact that MAL I binds both sialylated and unsialylated glycans under certain experimental conditions, including flow cytometry (11) . Lectin binding to ␣2,3-linked sialic acid inhibits EV70 attachment. As an alternative approach to determine if EV70 binding to sialylated receptors is linkage specific, we tested the abilities of lectins that exhibit specificity for the sialic acid linkage to inhibit radiolabeled EV70 binding to U-937 cells. Lectin specificities are shown in Table 2 . All three lectins inhibited EV70 binding to U-937 cells in a dose-dependent manner (Fig. 3A) . MAL I, which binds Neu5Ac␣2,3Gal but (11, 30, 38) , was Յ60%. Therefore, all three lectins could interfere directly with EV70 binding by competing for virus attachment sites containing ␣2,3-linked sialic acid. These results, in particular those obtained for MAL I, reinforce the conclusion drawn from the sialidase and sialyltransferase experiments that ␣2,3-linked sialic acid is an important component of EV70 attachment sites on U-937 cells. Lectin binding to oligosaccharides that do not contain ␣2,3-linked sialic acid may also contribute, to an unknown extent, to the inhibition that was observed by hindering EV70 access to virus attachment sites. Sialylated receptors on HCE cells and on U-937 cells are different. We wished to determine if the characteristics of EV70 binding to a more relevant (HCE) cell line were similar to what we have observed for HeLa cells (sialic acid and CD55 dependent) or for several other human cell lines, including U-937 cells (sialic acid dependent but CD55 independent) (1, 28, 35) . Binding of radiolabeled EV70 to HCE cells (Table 3) was sensitive to V. cholerae and S. pneumoniae sialidases but was resistant to PiPL-C and to blockade with a CD55-specific monoclonal antibody. EV70 attachment to HCE cells, therefore, as observed for U-937 cells, requires sialic acid but not CD55. Also, as shown in Fig. 4 , the yield of EV70 from sialidase-treated HCE cells was approximately 2 log units less than for untreated cells, indicating that binding to sialylated receptors is an important step in infection of HCE cells. As seen for other cell lines (1, 28), EV70 binding was also significantly inhibited by exposure of HCE cells to an inhibitor of O glycosylation, benzyl-GalNAc, but not by tunicamycin, which inhibits N-linked glycosylation (Table 3) . Differences were noted in lectin inhibition of EV70 binding to the two cell lines (Fig. 3 and Table 3 ). The maximum inhibitions of EV70 binding by MAL I (Ͼ80%) and SNA (Ͻ60%) were similar for the two cell lines; however, EV70 binding to HCE cells was more sensitive to inhibition by MAL I than was binding to U-937 cells. Also, MAL II blocked EV70 binding to HCE cells as efficiently as did MAL I (Ͼ80%) and more efficiently than it blocked binding to U-937 cells (ϳ50%) (Fig. 3 and Table 3 ). These differences may reflect differences in the nature or abundance of sialylated EV70 receptors on HCE cells and U-937 cells. To test this possibility, we examined the ability of proteinase K to inhibit EV70 binding to, and infection of, these two cell lines. As indicated in Table 3 , proteinase K treatment inhibited EV70 binding to HCE cells by more than 80% but had a much smaller inhibitory effect (Ͻ20%) on virus attachment to U-937 cells. As expected, CD55-dependent EV70 binding to HeLa cells was also sensitive to proteinase K. The yield of EV70 at 24 h after infection of proteinase K-treated HCE cells was reduced by almost 2 log units compared to untreated cells, but little difference was seen between virus yields from proteinase K-treated and untreated U-937 cells (Fig. 5) . Infectious-center assays also confirmed these results. Proteinase K treatment reduced the number of EV70-infected HCE cells by 90% but had no effect on the number of infected U-937 cells (data not shown). These results strongly suggest that a protein is the major attachment molecule for EV70 on HCE cells, but not on U-937 cells.
DISCUSSION
Taken together, the results of the experiments described here indicate that EV70 has a strong preference for binding to FIG. 4 . Sialidase treatment of HCE cells inhibits infection by EV70. HCE cells were incubated in the presence (ϩ) or absence (Ϫ) of S. pneumoniae sialidase (50 mU/ml) for 30 min at 37°C, washed twice with OptiMEM, and counted. The cells were infected with EV70 at an MOI of 5 PFU/cell at 32°C for 1 h and then washed three times with OptiMEM. At the indicated times after infection, samples were frozen at Ϫ80°C. The cells were subjected to two cycles of freezing and thawing to release virus, and the virus yield was determined by plaque assay on LLC-MK 2 cells in duplicate. This experiment was repeated twice. The data in the figure represent one experiment. O-linked glycans containing terminal sialic acid ␣2,3 linked to galactose, although the possibility that EV70 has the capacity to interact with glycans containing ␣2,6-linked sialic acid cannot be completely ruled out. V. cholerae sialidase cleaves terminal sialic acid but not sialic acid from branched internal positions, and S. pneumoniae sialidase, which efficiently stripped cells of EV70 binding sites, exhibits specificity for sialic acid that is ␣2,3 linked to galactose but is unable to release sialic acid linked to N-acetylgalactosamine in vitro (66) . The ␣2,3-sialyltransferases used in this study sialylate galactose residues (53) ( Table 1 ) and restored EV70 attachment sites to sialidase-treated cells to a much greater degree than did an ␣2,6-specific sialyltransferase. Because the ␣2,3-sialyltransferases are capable of adding sialic acid to O-linked glycans (53, 72) (Table 1) , the sialyltransferase data are also consistent with the observation that benzyl-GalNAc inhibits EV70 binding (1,28) (Table 3) , and support the hypothesis that the glycan recognized by EV70 is O linked. Inhibition of EV70 binding by the lectin MAL I, which exhibits specificity for galactose replaced with sialic acid attached by an ␣2,3 linkage but not an ␣2,6 linkage, was more pronounced than for lectin SNA, which binds sialic acid attached by ␣2,6 linkages (57, 58) . This also suggests that ␣-2,3-linked sialic acid is a component of an EV70 receptor. MAL II lectin (which inhibited virus binding to HCE cells but not U-937 cells) also interacts with glycans containing sialic acid linked to galactose by an ␣2,3 bond (11, 30, 37, 38) ( Table 2 ). EV70 appears to be able to interact with at least three different cell surface molecules. CD55 is the main binding molecule on HeLa cells, but a second sialylated molecule also serves as a receptor (1, 35) . Virus binding to HCE cells is inhibited by proteinase K, sialidase, and benzyl-GalNAc but is PiPL-C insensitive and CD55 independent. The simplest interpretation of these results is that the EV70 receptor on HCE cells is a non-GPI-anchored membrane glycoprotein, although the possibility that two distinct molecules are required for virus binding cannot be ruled out. CD55-independent attachment of EV70 to U-937 cells is also sensitive to sialidase, but not to proteinase K; therefore, the major attachment molecule for EV70 on U-937 cells is likely to be a nonproteinaceous molecule, such as a ganglioside, although a sialylated glycoprotein that is resistant to proteinase K cannot be ruled out. The differential inhibitory effects of Mal I and MAL II on EV70 binding to HCE cells and U-937 cells also support the idea that the EV70 receptors on these two cell lines are different. In any case, the virus appears to recognize sialic acid as part of glycoconjugates containing specific oligosaccharide structures and does not simply interact with all glycoconjugates carrying ␣2,3-linked sialic acid.
There are several examples where interactions between viruses and sialic acid attached by a particular glycosidic linkage contribute to host range, tissue tropism, and/or pathogenesis. Species specificity and tissue tropism of influenza A viruses correlate with sequence differences in the influenza HA that are associated with the preference of human influenza A viruses for ␣2,6-linked sialic acid and of avian influenza A viruses for ␣2,3-linked sialic acid (14, 31, 51, 52, 74) . Mutations in HA are critical for the adaptation of influenza A viruses to the human respiratory tract, where ␣2,6-linked sialic acid is expressed on columnar epithelial cells (9, 16, 44, 45) . Sialic acid linkage specificity also correlates with the tropism and pathogenicity of papovaviruses, for which sialic acid is an essential component of receptors. Recently, gangliosides containing terminal ␣2,3-linked sialic acid were shown to be receptors for mouse polyoma virus (67) . It has also been known for some time that highly tumorigenic, large-plaque variants of polyoma virus bind oligosaccharides terminating in Neu5Ac␣2,3Gal␤1, 3GalNAc, whereas less tumorigenic, small-plaque variants also recognize a branched oligosaccharide, Neu5Ac␣2,3Gal␤1, 3[Neu5Ac2,6]GalNAc (12, 25, 60) . Conversely, the receptor for JC virus on glial cells is believed to be an N-linked glycoprotein containing ␣2,6-linked sialic acid (43) , and the expression of ␣2,6-linked sialic acid, but not ␣2,3-linked sialic acid, correlates with the susceptibility of cells implicated in JC virus infection and spread, such as B lymphocytes in the tonsil and spleen and oligodendrocytes and astrocytes in the brain (22) . Transduction of central nervous system, eye, and lung cells by adeno-associated parvovirus AAV-5 is dependent on ␣2,3-Nlinked sialic acid (75) . The recent identification of plateletderived growth factor receptors ␣ and ␤ as receptors for AAV-5 is consistent with these characteristics, and the in vivo tropism of AAV-5 also correlates with the expression pattern of platelet-derived growth factor receptor ␣ (17, 19, 33) . Specific interactions between the 1 protein of type 1 reovirus and glycoconjugates containing ␣2,3-linked sialic acid appear to be directly involved in the adherence of type 1 reovirus to the apical surfaces of M cells in the intestinal mucosa (29) . A similar interaction may operate in the development of biliary disease in mice following infection by sialic acid binding strains of reovirus type 3 (7). We have identified two binding mole- 7 cells/ml) in OptiMEM, and incubated in the presence (ϩ) or absence (Ϫ) of proteinase K (200 g/ml) for 2 h at 37°C. Protease inhibitors were added for 10 min at room temperature, and the cells were washed twice, resuspended (3.5 ϫ 10 7 cells/ml) in OptiMEM, and infected with EV70 (MOI ϭ 5). Infected cells were washed five times and used in replication assays. HCE cells were seeded in six-well culture dishes. U-937 cells were maintained in stationary-suspension culture. At the indicated times after infection, samples (plates of HCE cells or aliquots of U-937 cells) were frozen at Ϫ80°C. The cells were subjected to two cycles of freezing and thawing to release virus, and the virus yield was determined by plaque assay on LLC-MK 2 cells in duplicate. This experiment was repeated twice for each cell line. The data in the figure represent one experiment.
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cules for EV70, sialic acid and CD55 (1, 28, 35, 36) , both of which are found on conjunctival and corneal epithelium or on cells derived from these tissues (18, 42, 46, 65) . Our in vitro data suggest that CD55 does not function as a receptor for EV70 on ocular tissue, despite its presence in the conjunctival and corneal epithelia, although this must still be confirmed in other model systems or in vivo. EV70 preferentially binds to ␣2,3-linked sialic acid, like adenovirus 37 (4, 5) , which causes keratoconjunctivitis, and like avian influenza viruses, several of which have been associated with conjunctivitis in humans (13, 24, 39, 64) , suggesting that the ocular tropism of these viruses is directly related to their interactions with ␣2,3-linked sialic acid. The use of sialic acid as a virus attachment molecule should not be considered a requirement for ocular tropism, however, since other viruses that do not use sialic acid as an attachment molecule, for example, herpes simplex virus, also infect the eye (59, 68) .
